Clinical and Functional Criteria for the State of Vital Activity and the Possibility of Rehabilitation of Patients and Disabled People with Age-related Cataracts

• Published in: Oftalmologii͡a Vol. 22; no. 2; pp. 443 - 448
• Main Authors: Korovyansky, Yu. A., Razumovskaya, A. M., Spiridonova, V. S., Kidraleeva, S. R.
• Format: Journal Article
• Language: English; Russian
• Published: Ophthalmology Publishing Group 27.06.2025
• Subjects: age cataract; ergonomic indicators; instillations; quinax
• ISSN: 1816-5095; 2500-0845
• DOI: 10.18008/1816-5095-2025-2-443-448

The purpose of the study was to evaluate the therapeutic effect of the drug Quinax when administered by the method of three instillations for 6 months to patients with initial age-related cataracts. Patients and methods. Treatment was given to 80 patients with an average age of 63 ± 2 years suffering from initial age-related cataracts. At the same time, the main group consisted of 40 patients who were injected with Quinax when it was administered by triplicate instillations for 6 months, the comparison group was 40 people who were treated with age-related cataracts using other conservative methods. Each patient underwent an ophthalmological study, which included: visometry, perimetry, refractometry, biomicroscopy, ophthalmoscopy, visual performance study, dark adaptation, and also analyzed the complaints presented in order to establish their impact on the quality of life of patients and disabled people with cataracts. Results. The results of the study showed the effectiveness of the use of the drug Quinax when administered by the method of three instillations for 6 months and revealed stabilization of visual functions: visual acuity and visual field to white, red and green colors, a decrease in visual fatigue, due to a decrease in glare, stabilization of dark adaptation and refraction. Conclusion. Assessment of the effectiveness of the use of the drug Quinax when administered by the method of three instillations for 6 months to patients with initial age-related cataracts showed a statistically significant positive therapeutic effect (89 %) in the form of stabilization of visual functions, and a positive ergonomic effect in the form of increased visual performance was noted. No side effects were observed among patients who received Quinax instillations.